P-276 High doses of eltrombopag are well-tolerated in conjunction with azacitidine and demonstrate encouraging activity in patients with MDS and AML.
Saved in:
| Title: | P-276 High doses of eltrombopag are well-tolerated in conjunction with azacitidine and demonstrate encouraging activity in patients with MDS and AML. |
|---|---|
| Authors: | Dickinson, M., Herbert, K., Sardjono, C., Le, T., Link, E., Zannino, D., Ruell, S., Seymour, J.F., Kenealy, M., Prince, H.M. |
| Source: | Leukemia Research. May2013 Supplement, Vol. 37, pS147-S147. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 89519294 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: P-276 High doses of eltrombopag are well-tolerated in conjunction with azacitidine and demonstrate encouraging activity in patients with MDS and AML. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Dickinson%2C+M%2E%22">Dickinson, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Herbert%2C+K%2E%22">Herbert, K.</searchLink><br /><searchLink fieldCode="AR" term="%22Sardjono%2C+C%2E%22">Sardjono, C.</searchLink><br /><searchLink fieldCode="AR" term="%22Le%2C+T%2E%22">Le, T.</searchLink><br /><searchLink fieldCode="AR" term="%22Link%2C+E%2E%22">Link, E.</searchLink><br /><searchLink fieldCode="AR" term="%22Zannino%2C+D%2E%22">Zannino, D.</searchLink><br /><searchLink fieldCode="AR" term="%22Ruell%2C+S%2E%22">Ruell, S.</searchLink><br /><searchLink fieldCode="AR" term="%22Seymour%2C+J%2EF%2E%22">Seymour, J.F.</searchLink><br /><searchLink fieldCode="AR" term="%22Kenealy%2C+M%2E%22">Kenealy, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Prince%2C+H%2EM%2E%22">Prince, H.M.</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Leukemia+Research%22">Leukemia Research</searchLink>. May2013 Supplement, Vol. 37, pS147-S147. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=89519294 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S0145-2126(13)70323-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S147 Titles: – TitleFull: P-276 High doses of eltrombopag are well-tolerated in conjunction with azacitidine and demonstrate encouraging activity in patients with MDS and AML. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Dickinson, M. – PersonEntity: Name: NameFull: Herbert, K. – PersonEntity: Name: NameFull: Sardjono, C. – PersonEntity: Name: NameFull: Le, T. – PersonEntity: Name: NameFull: Link, E. – PersonEntity: Name: NameFull: Zannino, D. – PersonEntity: Name: NameFull: Ruell, S. – PersonEntity: Name: NameFull: Seymour, J.F. – PersonEntity: Name: NameFull: Kenealy, M. – PersonEntity: Name: NameFull: Prince, H.M. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 05 Text: May2013 Supplement Type: published Y: 2013 Identifiers: – Type: issn-print Value: 01452126 Numbering: – Type: volume Value: 37 Titles: – TitleFull: Leukemia Research Type: main |
| ResultId | 1 |